Eli Lilly has officially crossed the $1 trillion market value threshold, marking a historic moment for the healthcare sector. This groundbreaking achievement positions Eli Lilly as the first pharmaceutical company to join the $1 trillion club, showcasing its significant growth and innovation in the industry. With recent stock performance and strategic advancements, investors are keenly watching this giant. Read on for the full story.